Volume 7, Issue 1 (2021)                   IEM 2021, 7(1): 77-99 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Derakhshan Sefidi M, Heidary L, Shams S. Prevalence of Imipenem-Resistant Acinetobacter baumannii isolates in Iran: A Meta-Analysis. IEM 2021; 7 (1) :77-99
URL: http://iem.modares.ac.ir/article-4-45888-en.html
1- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2- Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran , sshamsmed@gmail.com
Abstract:   (1648 Views)
Background: Acinetobacter baumannii is a gram-negative pathogen that is highly resistant to antibiotics. This bacterium can cause severe systemic infections, especially in hospitalized patients. Recently, antimicrobial-resistant Acinetobacter baumannii has become a life-threatening pathogen in Iran and around the world.
Materials & Methods: In this study, several Iranian and English databases were systematically searched to find all original and review articles investigating the prevalence of imipenem resistance in their sample size, while mentioning the source of clinical isolates, as well as the prevalence of antimicrobial resistance genes.  
Findings: Among genes, blaOXA-23 with a prevalence of 31% to 100% was responsible for global outbreaks of imipenem-resistant Acinetobacter baumannii and was presented in most of the hospital isolates. Our meta-analysis also revealed that 74.2% of Acinetobacter baumannii were resistant to imipenem in 122 clinical studies.
Conclusion: Our study highlighted a rapid increase in the rate of imipenem resistance in clinical isolates of Acinetobacter baumannii in Iran. The need for periodic antibiotic care system programs to monitor the administration and use of antibiotics
Full-Text [PDF 846 kb]   (557 Downloads)    
Article Type: Systematic Review | Subject: Bacteriology
Received: 2020/09/10 | Accepted: 2020/12/31 | Published: 2020/11/20

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.